# Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma

> **NCT02367924** · — · COMPLETED · sponsor: **PharmaMar, Spain** · enrollment: 130 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** trabectedin

## Key facts

- **NCT ID:** NCT02367924
- **Lead sponsor:** PharmaMar, Spain
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-16
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02367924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02367924, "Efficacy and Safety of Trabectedin (Yondelis®) in Patients With Advanced Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02367924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*